Correlation Between Tff Pharmaceuticals and Viracta Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tff Pharmaceuticals and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tff Pharmaceuticals and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tff Pharmaceuticals and Viracta Therapeutics, you can compare the effects of market volatilities on Tff Pharmaceuticals and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tff Pharmaceuticals with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tff Pharmaceuticals and Viracta Therapeutics.

Diversification Opportunities for Tff Pharmaceuticals and Viracta Therapeutics

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Tff and Viracta is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Tff Pharmaceuticals and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and Tff Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tff Pharmaceuticals are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of Tff Pharmaceuticals i.e., Tff Pharmaceuticals and Viracta Therapeutics go up and down completely randomly.

Pair Corralation between Tff Pharmaceuticals and Viracta Therapeutics

Given the investment horizon of 90 days Tff Pharmaceuticals is expected to under-perform the Viracta Therapeutics. In addition to that, Tff Pharmaceuticals is 3.5 times more volatile than Viracta Therapeutics. It trades about -0.34 of its total potential returns per unit of risk. Viracta Therapeutics is currently generating about -0.31 per unit of volatility. If you would invest  20.00  in Viracta Therapeutics on September 1, 2024 and sell it today you would lose (6.00) from holding Viracta Therapeutics or give up 30.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Tff Pharmaceuticals  vs.  Viracta Therapeutics

 Performance 
       Timeline  
Tff Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tff Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Viracta Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viracta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Tff Pharmaceuticals and Viracta Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tff Pharmaceuticals and Viracta Therapeutics

The main advantage of trading using opposite Tff Pharmaceuticals and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tff Pharmaceuticals position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.
The idea behind Tff Pharmaceuticals and Viracta Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets